The Patent Finder

Pisgah Laboratories, Inc.

Also on record
Records under this name other than the patents Pisgah Laboratories, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.

Back to Pisgah Laboratories, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,748,416Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
Lapsed on the fee record
Ended Jun 10, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 10, 2026USPTO record
US 8,569,329Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Lapsed on the fee record
Ended Oct 29, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 29, 2025USPTO record
US 8,569,330Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Lapsed on the fee record
Ended Oct 29, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 29, 2025USPTO record
US 8,476,291Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
Lapsed on the fee record
Ended Jul 2, 2025 · USPTO record
Lapsed on the fee recordEnded Jul 2, 2025USPTO record
US 8,367,693Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties
Lapsed on the fee record
Ended Feb 5, 2025 · USPTO record
Lapsed on the fee recordEnded Feb 5, 2025USPTO record
US 8,338,444Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties
Lapsed on the fee record
Ended Dec 25, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 25, 2024USPTO record
US 8,334,322Salts of physiologically active and psychoactive alkaloids and amines simultaneously exhibiting bioavailability and abuse resistance
Lapsed on the fee record
Ended Dec 18, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 18, 2024USPTO record
US 8,329,720Opioid salts and formulations exhibiting abuse deterrent and anti-dose dumping properties
Lapsed on the fee record
Ended Dec 11, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 11, 2024USPTO record
US 8,980,880Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Lapsed on the fee record
Ended Mar 17, 2023 · USPTO record
Lapsed on the fee recordEnded Mar 17, 2023USPTO record
US 8,957,067Abuse deterrent and anti-dose dumping pharmaceutical salts useful for the treatment of attention deficit/hyperactivity disorder
Lapsed on the fee record
Ended Feb 17, 2023 · USPTO record
Lapsed on the fee recordEnded Feb 17, 2023USPTO record
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited